KROS
Keros Therapeutics Inc
11.30$
-1.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.1% | 81.5% | 99.4% | 98.5% | 93.2% | 93.9% | 95.6% | 93.3% | |
| 84.8% | 64.1% | 98.7% | 90.1% | 91.0% | 89.5% | 90.9% | 85.0% | |
| 84.8% | 64.1% | 98.7% | 90.1% | 91.0% | 89.5% | 90.9% | 85.0% | |
| – | 8.4% | 0.1% | 7.1% | 0.3% | 0.3% | 0.7% | 1.9% | |
| – | 6.9% | 0.5% | 1.2% | -0.3% | 3.8% | – | – | |
| 5.0% | 17.5% | 0.6% | 0.5% | 0.7% | – | – | – | |
| 53.5% | 50.2% | 2.9% | 4.7% | 9.6% | 10.2% | 7.2% | 10.3% | |
| 41.8% | 40.9% | 2.7% | 4.6% | 5.4% | 6.6% | 4.5% | 6.0% | |
| 0.6% | 3.4% | 0.2% | 0.3% | 0.1% | 0.3% | 0.3% | 0.7% | |
| 1.8% | 19.1% | 0.8% | 1.4% | 1.1% | 1.5% | 0.7% | 0.6% | |
| 8.7% | 45.2% | – | – | – | – | – | – | |
| 46.5% | 49.8% | 97.1% | 95.3% | 90.4% | 89.8% | 92.8% | 89.7% | |
| -26.7% | -179.4% | -24.1% | -48.5% | -74.5% | -103.1% | -92.4% | -142.5% | |
| 32.4% | 81.1% | 5.8% | 9.1% | 8.2% | 8.0% | 6.1% | 11.2% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.